REGULAR ARTICLE
Induction of Nitric Oxide Synthase and Concomitant Suppression of Superoxide Dismutases in Experimental Colitis in Rats

https://doi.org/10.1006/abbi.1995.9932Get rights and content

Abstract

Reactive oxygen species are thought to play an important role in some bowel diseases. In order to evaluate the participation of nitric oxide and superoxide in such diseases, we examined the expression of nitric oxide synthase (NOS) and superoxide dismutase (SOD) as well as their activities in whole excised colons of rats with colitis induced by intralumenal administration of 2,4,6-trinitrobenzenesulfonic acid. A marked increase in the inducible form of NOS mRNA was detected and NOS activity was coincidentally augmented in the group administered unbuffered TNBS (pH 1.0), in which severe inflammation was revealed by microscopic examination and myeloperoxidase activity of invading neutrophils in the tissues. The levels of the Mn- and Cu,Zn-SOD proteins as well as SOD activity were suppressed, although expression of the Mn-SOD mRNA was enhanced in colitis tissues. The elevation of NOS activity and the suppression of SOD activity occurred concomitantly at the stage of severe inflammation. This would increase peroxynitrite formation from superoxide and nitric oxide and enhance the tissue damage in experimental colitis.

References (0)

Cited by (79)

  • Elevated ER stress exacerbates dextran sulfate sodium-induced colitis in PRDX4-knockout mice

    2019, Free Radical Biology and Medicine
    Citation Excerpt :

    The data from our study are consistent with a mechanism in which impaired unfolded proteins consequent to PRDX4 deficiency triggers ER stress and ultimately the death of epithelial cells. Among principle antioxidative enzymes, SOD1 and SOD2 are reportedly decreased in trinitrobenzenesulfonic acid-induced colitis model rats [46]. However, our data on DSS-induced colitis model mice showed no significant changes in the levels of SOD1 and SOD2 but rather indicated a prominent decrease in the levels of GPX1 and GPX2 (Fig. 4), which might also be associated with the aggravated intestinal damage.

  • Ameliorative effect of chromium-D-phenylalanine complex on indomethacin-induced inflammatory bowel disease in rats

    2017, Biomedicine and Pharmacotherapy
    Citation Excerpt :

    IBD affects men and women equally, while the incidence for CD is higher in women whereas UC in men [3]. Inflammatory mediators such as cytokines, eicosanoids and reactive oxygen metabolites play a crucial role in the development and persistence of IBD [4,5]. Most of the current therapies for IBD involve treatment with glucocorticoids, 5-aminosalicyclic acid and immunosuppressive drugs, but these are not safe as they may produce serious complications and toxic side effects such as nephrotoxicity, pulmonary toxicity and male infertility [3,6,7].

  • 1,3,4-Thiadiazole derivatives as selective inhibitors of iNOS versus nNOS: Synthesis and structure-activity dependence

    2012, European Journal of Medicinal Chemistry
    Citation Excerpt :

    Moreover, selective inhibitors may also constitute useful pharmacological tools in the research of NO biological functions. In previous experiments, we found that melatonin 1, the main compound secreted by the pineal gland, inhibits the rat striatum nNOS activity in a dose-dependent manner [20]. On the other hand, in a further paper, it was found that melatonin acts as non-competitive inhibitors of nNOS, being calmodulin the target involved in the nNOS inhibition activity of this compound [21].

  • Phenylpyrrole derivatives as neural and inducible nitric oxide synthase (nNOS and iNOS) inhibitors

    2009, European Journal of Medicinal Chemistry
    Citation Excerpt :

    Our search group has reported several nNOS inhibitors with a kynurenine structure 2, showing a significant nNOS inhibition activity [34,35]. A second type of nNOS inhibitors described by our research group show a kinurenamine structure 3 [36] among them the main melatonin brain metabolite (AMK: 3, R1 = MeO, R2 = Me). All these compounds inhibit nNOS in a dose-dependent manner, and it has been found that AMK rather than melatonin is the active metabolite against nNOS in rat striatum [37].

View all citing articles on Scopus
View full text